ArticleOncoTargets and therapy2019

miR-29a inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting DPP4.

Yufei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.